GE HealthCare Technologies (GEHC) Current Deferred Revenue (2022 - 2026)

GE HealthCare Technologies (GEHC) has reported Current Deferred Revenue for 5 consecutive years, with $3.1 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Current Deferred Revenue rose 12.39% year-over-year to $3.1 billion; the trailing twelve-month figure through Jun 2026 stood at $3.1 billion (up 12.39% YoY), and the FY2025 full-year result was $2.9 billion, up 10.27% from the prior year.
• Current Deferred Revenue advanced to $3.1 billion in Q2 2026 per GEHC's latest filing, from $3.0 billion in the prior quarter.
• Across five years, Current Deferred Revenue topped out at $3.1 billion in Q2 2026 and bottomed at $2.5 billion in Q4 2022.
• Historically, Current Deferred Revenue has averaged $2.7 billion across 5 years, with a median of $2.6 billion in 2024.
• The sharpest annual moves came in 2024 and 2026: Current Deferred Revenue declined 4.29% in 2024, then grew 13.74% in 2026.
• Over 5 years, Current Deferred Revenue stood at $2.5 billion in 2022, then advanced by 3.84% to $2.6 billion in 2023, then advanced by 0.23% to $2.6 billion in 2024, then rose by 10.27% to $2.9 billion in 2025, then rose by 5.45% to $3.1 billion in 2026.
• According to Business Quant data, Current Deferred Revenue over the past three periods registered $3.1 billion, $3.0 billion, and $2.9 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.